Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand: Bangkok, Thailand Thursday, May 29, 2025, 11:00 Hrs [IST] Zuellig Pharma, a ...

Mounjaro (tirzepatide) will be available in the market from the end of May 2025BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zu ...

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounja ...

offering a single medication that can address both conditions through an easy-to-use prefilled pen. Mounjaro ® KwikPen ® (tirzepatide injection) is available in 2.5 mg, 5 mg, 7.5 mg and 10 mg ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Managing type 2 diabetes goes beyond diet and exercise—it often involves choosing the right medication. One of the most ...

Grant has been on a GLP-1 medication for three years — first Mounjaro, then Zepbound ... a vial challenging after years of using prefilled injector pens. She said she wishes it were cheaper ...